HIV-1 Specific CD4 Responses in Primary HIV-1 Infection predict disease progression in the SPARTAC Trial

Objectives Immune factors determining clinical progression following HIV-1 infection remain unclear. The SPARTAC trial randomised 366 participants in primary HIV infection (PHI) to different short course therapies. The aim of this study was to investigate how early immune responses in PHI impacted c...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Frater, A, Ewings, F, Hurst, J, Brown, H, Robinson, N, Fidler, S, Babiker, A, Weber, J, Porter, K, Phillips, R
Formatua: Journal article
Hizkuntza:English
Argitaratua: Wolters Kluwer 2013